Evidence map›Paper›PMID 31599131›Full record

ArticlePhysiological reports2019

Effects of clenbuterol administration on mitochondrial morphology and its regulatory proteins in rat skeletal muscle.

Yu Kitaoka, Daiki Watanabe, Yudai Nonaka, Kazuyoshi Yagishita, Yutaka Kano, Daisuke Hoshino

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Yu KitaokaDepartment of Human Sciences, Kanagawa University, Yokohama, Japan.
Daiki WatanabeGraduate School of Integrated Arts and Sciences, Hiroshima University, Hiroshima, Japan.
Yudai NonakaDepartment of Engineering Science, The University of Electro-communications, Chofu, Tokyo, Japan.
Kazuyoshi YagishitaClinical Center for Sports Medicine and Sports Dentistry, Hyperbaric Medical Center/Sports Medicine Clinical Center, Medical Hospital of Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
Yutaka KanoDepartment of Engineering Science, The University of Electro-communications, Chofu, Tokyo, Japan.
Daisuke HoshinoDepartment of Engineering Science, The University of Electro-communications, Chofu, Tokyo, Japan.ORCID 0000-0003-0065-8470
University of Electro-Communications · JPHiroshima University · JPKanagawa University · JPTokyo Medical and Dental University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clenbuterol induces a slow-to-fast fiber type transition in skeletal muscle. This muscle fiber transition decreased mitochondrial oxidative capacity and respiratory function. We hypothesized that the clenbuterol-mediated reduction in oxidative capacity is associated with the alteration in mitochondrial morphology. To verify this hypothesis, we examined whether clenbuterol alters mitochondrial morphology and mitochondrial regulatory proteins in rat skeletal muscle. Clenbuterol was administered to rats via drinking water (30 mg/L) for 3 weeks. Myosin heavy chain (MHC) isoform composition, mitochondrial morphology, and fusion and fission regulatory protein levels in deep region and superficial region in tibialis anterior (TA) muscles were assessed. Clenbuterol induced the fiber type transition from slow to fast in both the regions of TA. The levels of optic atrophy protein 1, mitofusin 2, and mitochondrial fission 1, but not of dynamin-related protein 1, significantly decreased in deep and superficial muscles after clenbuterol administration (P < 0.01). Also, observation using the transmission electron microscopy showed a decrease in mitochondrial volume (P < 0.05) and an increase in proportion of continuous or interacting mitochondria across Z-lines (P < 0.05). We showed that clenbuterol administration induces a transition in the muscle fiber type composition toward fast phenotype and causes alterations in mitochondrial morphology with a concomitant decrease in mitochondrial fusion and fission regulatory protein levels. These mitochondrial morphological alterations may influence deleterious effects on skeletal muscle metabolism.

Indexed as

Adrenergic beta-AgonistsAnimalsClenbuterolMaleMitochondriaMitochondrial ProteinsMuscle, SkeletalRatsRats, WistarAdrenergic beta-AgonistsClenbuterolMitochondrial Proteinsmitochondrial dynamicsmuscle fiber typeβ2 adrenergic agonist

Identifiers

PMID31599131
PMCPMC6785658
OpenAlexW2979817600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.